Forte Biosciences, Inc.
NASDAQ:FBRXBiotechnology
Healthcare
$76.99 +1.71%
+$0.30 today
- Market cap
- $1.58B
- Beta
- 2.87
- P/E (TTM)
- -42.1
- EPS (TTM)
- -$0.43
52W Low $9.10High $35.80
Volume 0.00M
Average 0.30M
Price history
Forte Biosciences, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+311.49%
Period high
$76.99
Period low
$15.67
Latest
$76.99
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 14D9/A | Aug 21, 2026 | Aug 21, 2026 | |
| SC 14D9/A | Aug 19, 2026 | Aug 19, 2026 | |
| SC TO-T/A | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G/A | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G/A | Aug 7, 2026 | Aug 7, 2026 | |
| SC 13G/A | Aug 7, 2026 | Aug 7, 2026 | |
| SC TO-T | Aug 6, 2026 | Aug 6, 2026 | |
| SC TO-T/A | Aug 6, 2026 | Aug 6, 2026 | |
| SC 14D9 | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | Jul 28, 2026 | Jul 28, 2026 |
Competitors
Who does Forte Biosciences, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about FBRX's filings, answered from its disclosures.
What is the latest FBRX filing?
The latest filing shown is SC 14D9/A dated Aug 21, 2026.
How many recent filings does FBRX have?
Intrinsic Alpha currently shows 20 recent filings for FBRX.
Continue the stock analysis
Jump to another research area for this company.